Connect with us

Technology

Forging New Paths: Alfasigma Group and Fangzhou Inc. Chart a Course for Internet Healthcare

Published

on

SHANGHAI, Nov. 19, 2024 /PRNewswire/ — On November 13th, a high-level delegation from the Alfasigma Group, led by Mr. Andriy Samoylovych, Chief Commercial Officer of Global Growth Markets, and Ms. Zhou Qin, General Manager of Alfasigma China, met with Dr. Xie Fangmin, Chairman and CEO of Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), at the Company’s offices in Shanghai. The two companies discussed current trends in China’s Internet healthcare sector, along with potential areas for future collaboration.

Embracing Digital Evolution

The emergence of the Internet and digital technology has expanded the possibilities for Internet healthcare in China. Increasing numbers of patients are looking online for medical services that bring greater convenience and an improved customer experience. “The evolution of Internet hospitals in China is a gradual process that relies not only on technological advancements, but also fundamentally on developing patients’ acceptance of new healthcare delivery models,” elaborated Dr. Xie.

By leveraging an innovative hybrid model which combines initial offline consultations with online follow-ups, Fangzhou has boosted patients’ acceptance and trust in its Internet Hospital services. This model has facilitated more convenient communication between doctors and patients, fostering deeper relationships and engagement, which are crucial to improving patients’ treatment adherence.

Strategic Collaboration to Enhance Healthcare Delivery

Mr. Andriy Samoylovych engaged in a comprehensive discussion with the Fangzhou team, addressing topics such as expanding patient access to innovative drugs, the current landscape of Internet healthcare in China, and the insights gained from Internet based doctor/patient education.

For many years, Fangzhou and Alfasigma Group have engaged in extensive collaboration across multiple therapeutic areas, including cardiovascular health, vascular surgery, nephrology, endocrinology, hepatology, infectious diseases, gastroenterology, and reproductive health. The meeting highlighted the latest achievements of both organizations while outlining directions for future partnership. Fangzhou and Alfasigma Group are eager to work together to drive innovation and enhance the delivery of Internet healthcare.

About Fangzhou Inc.

Fangzhou Inc. (06086.HK) is China’s leading online chronic disease management platform. With 45.6 million registered users and 217,000 registered doctors on its platform (as of June 30, 2024), the Company provides tailored medical care and precision medicine for a growing population of chronic disease patients. For more details, visit https://investors.jianke.com.

About Alfasigma

Alfasigma is an international pharmaceutical company founded in Italy, and operating in over 100 countries worldwide (through direct branches, affiliates and subsidiaries). With more than 75 years of history, Alfasigma has a long track record in the research, development, production and distribution of innovative therapeutic indications. Its product portfolio spans specialty care, primary care and consumer care in five main areas: Gastroenterology, in which it is a leader, Vascular, Rheumatology, Metabolic, Nutraceuticals & Medical foods.

Media Contact
For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: pr@jianke.com

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements

View original content to download multimedia:https://www.prnewswire.com/news-releases/forging-new-paths-alfasigma-group-and-fangzhou-inc-chart-a-course-for-internet-healthcare-302310791.html

SOURCE Fangzhou Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Axilion Makes a Mark at ITS Texas/TexITE Joint Conference

Published

on

By

AUSTIN, Texas, Nov. 20, 2024 /PRNewswire/ —  Axilion (TASE: AILN) continues to solidify its presence in the U.S. traffic optimization market with a standout participation at the ITS Texas/TexITE Joint Conference. The company showcased its innovative X Way platform at an exhibitor booth and presentation on Friday’s panel, “Signal Timing Session I: Impact of Integrated Advanced Technologies in Traffic Management.”

The conference, which drew 781 participants—including traffic engineers, transportation professionals, and key decision-makers—provided an ideal stage for Axilion to highlight its cutting-edge solutions to the southern U.S. region. The Axilion booth attracted numerous visitors, keen to explore live demonstrations of the X Way platform, which leverages AI and digital twin technology to revolutionize traffic signal optimization. At the conference, Axilion presented the excellent results achieved in its latest pilots in the US, with significant improvements in traffic loads and times.

During the signal timing session, Axilion, delivered a compelling case study detailing the use of digital twin and reinforcement learning technologies to optimize traffic signal timing in Las Vegas. The session, attended by 96 participants, received strong positive feedback and generated additional booth traffic from those eager to learn more about the platform’s capabilities.

About Axilion

Axilion’s unique digital twin technology sets a global standard by offering a scalable, pure software signal optimization solution. Powered by a homegrown micro-simulation and state-of- the-art optimization engine, Axilion empowers traffic engineers with the ability to initiate AI- driven optimization processes aligned with decision-makers’ policy. Fusing both detector and probe data, a real-time traffic demand database emerged and set a solid foundation for the solution. The culmination is a system where precise strategies can be devised, evaluated, and perfected, all before real-world deployment.

The Company’s site: https://axilion.com/about/

View original content:https://www.prnewswire.com/news-releases/axilion-makes-a-mark-at-its-texastexite-joint-conference-302310953.html

SOURCE Axilion Smart Mobility

Continue Reading

Technology

Tata Elxsi, DENSO and AAtek Inaugurate ‘Robotics and Automation Innovation Lab’ in Frankfurt

Published

on

By

FRANKFURT, Germany and BENGALURU, India, Nov. 20, 2024 /PRNewswire/ — Tata Elxsi, a global leader in design and technology services, in partnership with DENSO Robotics Europe and AAtek, announced the inauguration of the ‘Robotics and Automation Innovation Lab’ at its Frankfurt office. This state-of-the-art facility aims to drive the future of robotics automation across sectors such as medical devices, pharmaceuticals, life sciences and food science.

Equipped for both proof-of-concept (POC) and full-scale development, the lab will serve as a research and development hub, focusing on modular automation, accelerating product development, and simplifying maintenance, to meet global demand for automation solutions. This includes live demonstrations of high-precision and modular robotic implementations in cell/tissue culture, diagnostics, and sterilised environments.

The new facility will specialise in key areas, leveraging AI-driven analytics to support personalised medicine, automated handling of cell cultures in sterile environments, liquid handling and dispensing solutions, hospital lab automation, drug discovery, bioprocessing, and diagnostics. The centre will provide services, including product design and engineering, application development, platform engineering, and regulatory compliance support.

This unique combination of state-of-the-art technology and deep automation expertise provides customers with a platform to co-create, test, and deploy robotic solutions designed to meet the specific regulatory and operational challenges of the healthcare industry.

Designed to foster innovation in the region, the lab is also open to researchers and students from the Frankfurt Innovation Center (FIZ) and the startup ecosystem in the Hessen region.

The launch event was inaugurated by key leaders from all three companies, including Manjunath Kulkarni, VP of Client Relationship at Tata Elxsi; Arun Damodaran, Founder and CEO of AAtek Group; Dirk Schöffler, Head of DENSO Robotics Europe; and Bhupendra Singh Nikhurpa – Consul Commerce, Consulate General of IndiaFrankfurt.

Commenting on the inauguration, Raghav Yesodha, Director, Healthcare & Life Sciences, at Tata Elxsi, said, “This lab marks an important milestone in our efforts to bring together the best of Japanese innovation, German precision, and Tata Elxsi’s expertise in med-tech, regulatory compliance, and automation. Together with DENSO’s robotics leadership and AAtek’s integration capabilities, we are poised to accelerate innovation and product development in healthcare automation, enabling our customers to stay ahead of evolving market needs.”

Arun Damodaran, Founder and CEO of AAtek Group, emphasised the power of collaboration, saying, “While we are strong individually, together with Tata Elxsi and DENSO, we are even stronger. This partnership enables us to deliver comprehensive, end-to-end solutions as a one-stop shop for robotics, automation, and Industry 4.0, focusing on the life sciences, pharmaceutical, and healthcare sectors.”

Dirk Schöffler, Head of DENSO Robotics Europe, stated, “DENSO being a leader in robotic technology and contributing towards the Robotics and Automation Innovation Lab offers valuable opportunities to develop fresh perspectives and cutting-edge solutions through ‘Crafting the Core’, driving creativity and accelerating progress to meet current market demands beyond traditional boundaries.”

With a roadmap for future expansion in USA and India, this lab is strategically positioned to become a key enabler in the global robotics and automation landscape, helping customers navigate the complex and rapidly evolving healthcare automation space.

About Tata Elxsi

Tata Elxsi is a global design and technology services company headquartered in Bangalore. It addresses the healthcare, automotive, broadcast, and communications consumer electronics industries. This is supported by a network of design studios, development centres, and offices worldwide. Tata Elxsi’s Healthcare & Life Sciences practice is ISO 13485 certified and collaborates with prominent medical device and pharmaceutical OEMs, as well as technology companies. With a comprehensive services and solutions portfolio, Tata Elxsi adds value at every stage of the customer’s product development lifecycle. Recognised as a leader in technology consulting, new product design, development, verification & validation, as well as regulatory compliance services, Tata Elxsi is a trusted name in the industry. For more information, visit www.tataelxsi.com

About AAtek

AAtek Group Head Quartered by AAtek GmbH at Frankfurt am Main, Germany 2011, acts as a Technical Knowledge Transfer Centre with its Affiliate company AAtek Robo Pvt. Ltd., in Coimbatore India. AAtek Robo Pvt. Ltd is also the Official DENSO Robotics Europe Distributor and System Integrator in the Indian Market. It also handles the Projects, Application Design, and Development from India. AAtek is a Holistic Global System Integrator, implementing Agile Automation through Internet of Things, Data Analytics, Artificial Intelligence and Robotics for Life-Science Industries, Laboratories and others. For more information about AATek, visit aatek.de

About DENSO Corporation

Globally headquartered in Kariya, Japan, DENSO is a $47.2 billion leading mobility supplier that develops advanced technology and components for nearly every vehicle make and model on the road today. With manufacturing at its core, DENSO invests in around 180 facilities worldwide to provide opportunities for rewarding careers and to produce cutting-edge electrification, powertrain, thermal and mobility electronics products, among others, that change how the world moves. In developing such solutions, the company’s 162,000 global employees are paving the way to a mobility future that improves lives, eliminates traffic accidents, and preserves the environment. DENSO spent around 7.7 percent of its global consolidated sales on research and development in the fiscal year ending March 31, 2024. For more information about DENSO’s operations worldwide, visit https://www.denso.com/global.

Logo: https://mma.prnewswire.com/media/742257/4913784/Tata_Elxsi_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/tata-elxsi-denso-and-aatek-inaugurate-robotics-and-automation-innovation-lab-in-frankfurt-302311080.html

Continue Reading

Technology

The Lazarus Practice: Ex Goldman Sachs and Headspace Leaders Pioneer a New Era of Personalised Mental Health Support in the United Kingdom

Published

on

By

LONDON, Nov. 20, 2024 /PRNewswire/ — The Lazarus Practice launches today offering advanced psychotherapy and groundbreaking ‘multimodal’ therapeutic pathways.

The practice is not just a service, it’s a revolution in mental health care and represents a beacon of hope at a time when the UK faces a pervasive, worsening and indiscriminate nationwide mental health crisis that annually affects as many as one in four individuals, from all walks of life.

The practice is spearheaded by visionary founders Dr Ian Dodd, a former Goldman Sachs executive who experienced a severe burnout and depression, and Dr David Cox, ex-Chief Medical Officer at Headspace. It emerges from a critical need to overcome the widespread failures of the majority of private and public mental health services.

“Like many others, I’ve experienced first-hand how private and public mental health services most often fall well short of their promises. The words ‘quality’, ‘personalised’, and ‘recovery-oriented’ are widely misused and abused, leaving me horrified given the terrible human costs and suffering associated with such misrepresentation,” says Co-Founder and CEO, Dr Ian Dodd. “Our mission is simple: to furnish the highest calibre and most effective mental health support available, crafted to fit seamlessly into the lives of those who demand the utmost in quality and confidentiality.”

Bringing Hope to discerning clients

The practice recognises the, often silent, psychological costs of living demanding, high-pressure or high- stakes lifestyles. Its services are bespoke, intelligent, discreet and entirely human and it is well positioned to support successful, high-performing, prominent or high net worth individuals and their loved ones. It addresses the nuanced challenges faced by this demographic, ensuring they receive the support they need to thrive.

Its services are rooted in good science and every component has been designed by highly skilled and knowledgeable experts. “Life changing outcomes are unlocked through the application of deep expertise, which allows for a very detailed understanding of our clients needs at any point in time and the provision of powerful, appropriate and precise support,” says Dr Dodd. “We have an extraordinary team, the very best, most of whom possess decades of experience supporting clients in changing their lives for the better.”

Advanced Psychotherapy

The practice offers outcome-focused psychotherapy programmes tailored to each client, delivered by highly knowledgeable therapists possessing the required skills and having significant experience of supporting others, with similar needs, in successfully achieving their desired outcomes. “The widespread problems with psychotherapy today, of which there are many, explain why of those starting it, more than half drop out (most quickly and never to return), less than one in ten achieve their outcomes, one in twenty people end up harmed or feeling worse,and the remainder report at best modest, often no, benefits. There is a HUGE unspoken problem,” says Dr Dodd.

Transformative ‘Multimodal’ Therapeutic Pathways

Groundbreaking multimodal pathways have the greatest potential for efficiently transforming client lives, with every client quickly experiencing a close-knit and expert multidisciplinary team coming around them comprising expertise in psychotherapy, sleep, nutrition, mindfulness and movement. A dedicated Client Advocate, a very experienced psychological practitioner, monitors progress, working to ensure that the best path is always being followed. “Simply put, our multimodal pathways transform both mental health and lives,” says Dr Dodd. “They vastly surpass the potential of psychotherapy alone and have the greatest potential to return to full mental health clients who find themselves struggling.” He adds “they work, they are game- and life-changing and our offering here is unique.”

A Vision for the Future

The Lazarus Practice is committed to revolutionising mental health support, providing cutting-edge, personalised services that foster genuine healing. It launches at a time when the need for trusted, effective mental health services has never been more acute and it stands ready to make a significant, positive impact on the lives of those it serves. 

For media inquiries, please contact:

Darcie Tanner, CMO
darcie@thelazaruspractice.com
07731 399 314

To learn more about The Lazarus Practice, visit:

Website: https://www.thelazaruspractice.com/
Instagram: https://www.instagram.com/thelazaruspractice/
LinkedIn: https://uk.linkedin.com/company/the-lazarus-practice

You can find a logo for The Lazarus Practice here: https://drive.google.com/file/d/1uR_5ERMc-O8ac4jFXAYgKQntOXMZJOHB/view?usp=sharing

 

View original content:https://www.prnewswire.co.uk/news-releases/the-lazarus-practice-ex-goldman-sachs-and-headspace-leaders-pioneer-a-new-era-of-personalised-mental-health-support-in-the-united-kingdom-302310446.html

Continue Reading

Trending